Moomoo AI 已提取核心信息
Kevin K. Buckbee, an officer at AbbVie Inc., is set to sell 5,145 shares of the company's common stock on 02/29/2024, with an aggregate market value of $908,705.02. The shares to be sold were acquired through a mix of performance shares and retail purchases. A total of 5,099 shares were obtained as performance shares on two separate occasions, one batch on 02/28/2023 and the other on 02/28/2024. The remaining 46 shares were purchased in retail transactions spanning from 05/16/2022 to 02/15/2024. The sales notice was filed on the same day as the planned sale.
Kevin K. Buckbee, an officer at AbbVie Inc., is set to sell 5,145 shares of the company's common stock on 02/29/2024, with an aggregate market value of $908,705.02. The shares to be sold were acquired through a mix of performance shares and retail purchases. A total of 5,099 shares were obtained as performance shares on two separate occasions, one batch on 02/28/2023 and the other on 02/28/2024. The remaining 46 shares were purchased in retail transactions spanning from 05/16/2022 to 02/15/2024. The sales notice was filed on the same day as the planned sale.
艾伯维公司高管凯文·巴克比定于2024年2月29日出售该公司5,145股普通股，总市值为908,705.02美元。待出售的股票是通过绩效股票和零售购买的混合方式收购的。在两个不同的场合共获得了5,099股绩效股票，一批于2023年2月28日，另一批于2024年2月28日。其余46股股票是在2022年5月16日至2024年2月15日期间的零售交易中购买的。销售通知是在计划销售的同一天提交的。
艾伯维公司高管凯文·巴克比定于2024年2月29日出售该公司5,145股普通股，总市值为908,705.02美元。待出售的股票是通过绩效股票和零售购买的混合方式收购的。在两个不同的场合共获得了5,099股绩效股票，一批于2023年2月28日，另一批于2024年2月28日。其余46股股票是在2022年5月16日至2024年2月15日期间的零售交易中购买的。销售通知是在计划销售的同一天提交的。
有用
没用